Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Hubbard

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
RNA (New York, N.Y.)|February 16, 2011
A robust in vivo positive-readout system for monitoring siRNA delivery to xenograft tumorsXiaoyu Lin, Leiming Li, Rongqi Wang, et al.
The Journal of Biological Chemistry|June 19, 2008
Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activationJulie L Wilsbacher, Qian Zhang, Lora A Tucker, et al.
Molecular Cancer Therapeutics|August 15, 2013
Developing lipid nanoparticle-based siRNA therapeutics for hepatocellular carcinoma using an integrated approachLeiming Li, Rongqi Wang, Denise Wilcox, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2007
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)Robert D Hubbard, Nwe Y Bamaung, Fabio Palazzo, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinasesGary T Wang, Robert A Mantei, Robert D Hubbard, et al.
BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinasesRobert D Hubbard, Nwe Y Bamaung, Steve D Fidanze, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinasesSteve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
RNA (New York, N.Y.)|February 16, 2011
A robust in vivo positive-readout system for monitoring siRNA delivery to xenograft tumorsXiaoyu Lin, Leiming Li, Rongqi Wang, et al.
The Journal of Biological Chemistry|June 19, 2008
Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activationJulie L Wilsbacher, Qian Zhang, Lora A Tucker, et al.
Molecular Cancer Therapeutics|August 15, 2013
Developing lipid nanoparticle-based siRNA therapeutics for hepatocellular carcinoma using an integrated approachLeiming Li, Rongqi Wang, Denise Wilcox, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2007
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR)Robert D Hubbard, Nwe Y Bamaung, Fabio Palazzo, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinasesGary T Wang, Robert A Mantei, Robert D Hubbard, et al.
BMC Cancer|September 8, 2009
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605William N Pappano, Paul M Jung, Jonathan A Meulbroek, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinasesRobert D Hubbard, Nwe Y Bamaung, Steve D Fidanze, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2009
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitorsAlex G Waterson, Kimberly G Petrov, Keith R Hornberger, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinasesSteve D Fidanze, Scott A Erickson, Gary T Wang, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Pageof 3